Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results.

Thurau, S R; Diedrichs-Möhring, M; Fricke, H; Arbogast, S; Wildner, G

Thurau, S R; Diedrichs-Möhring, M; Fricke, H; Arbogast, S; Wildner, G.

Affiliation

Thurau SR; Section of Immunobiology, University Eye Hospital, München, Germany. 100 023.761@compuserve.com

Immunol Lett ; 57(1-3): 193-201, 1997 Jun 01.

Article in En | MEDLINE | ID: mdl-9232451

Subject(s)

Autoimmune Diseases/drug therapy; HLA Antigens/therapeutic use; Peptides/therapeutic use; Uveitis/drug therapy; Administration, Oral; Adolescent; Adult; Animals; Arrestin/chemistry; Autoimmune Diseases/immunology; Cross Reactions; Dose-Response Relationship, Drug; Feasibility Studies; Female; Follow-Up Studies; HLA Antigens/chemistry; HLA Antigens/immunology; HLA-B27 Antigen/chemistry; Humans; Male; Molecular Mimicry; Peptides/chemistry; Peptides/immunology; Rats; Rats, Inbred Lew; Time Factors; Uveitis/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Autoimmune Diseases / Uveitis / HLA Antigens Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Ethics Limits: Adolescent / Adult / Animals / Female / Humans / Male Language: En Journal: Immunol Lett Year: 1997 Document type: Article Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links